Clare Biomedical

Clare Biomedical (stock ticker: CLRE) is a large medical technology corporation primarily specialising in cyborg implants, medical imaging and spatial surgery systems, and brain-computer interface technologies. It is a competitor to BioCorp and Sakura Cybernetics, and various other corporations. The current CEO of Clare Biomedical is Dr. Sofia Fisher.

Clare is unique in a narrative sense in that it has been implicated in far less controversies than corporations such as BioCorp. It is somewhat of a middle ground between the solely profit-driven and the non-profit players; it aims to remain ethically grounded, but isn’t afraid of making its fair share of money on the side.